|
1) Tsukimoto I, Tawa A, Horibe K, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009; 27: 4007-13
|
|
|
|
2) Jo A, Tsukimoto I, Ishii E, et al. Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis. Br J Haematol. 2009; 144: 917-29
|
|
|
|
|
|
3) Coenen EA, Raimondi SC, Harbott J, et al. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. Blood. 2011; 117: 7102-11
|
|
|
|
|
|
4) Shimada A, Taki T, Tabuchi K, et al. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group. Pediatr Blood Cancer. 2008; 50: 264-9
|
|
|
|
|
|
5) Shimada A, Taki T, Tabuchi K, et al. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8; 21): a study of the Japanese Childhood AML Cooperative Study Group. Blood. 2006; 107: 1806-9
|
|
|
|
|
|
6) Pollard JA, Alonzo TA, Gerbing RB, et al. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. Blood. 2010; 115: 2372-9
|
|
|
|
|
|
7) Mizushima Y, Taki T, Shimada A, et al. Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study Group. Int J Hematol. 2010; 91: 831-7
|
|
|
|
|
8) Ho PA, Kutny MA, Alonzo TA, et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Childrenʼs Oncology Group. Pediatr Blood Cancer. 2011; 57: 204-9
|
|
|
|
|
|
9) Andersson AK, Miller DW, Lynch JA, et al. IDH1 and IDH2 mutations in pediatric acute leukemia. Leukemia. 2011, Epub ahead of print
|
|
|
|
|
|
10) Damm F, Thol F, Hollink I, et al. Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups. Leukemia. 2011, Epub ahead of print
|
|
|
|
|
|
11) Suzuki T, Kiyoi H, Ozeki K, et al. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood. 2005; 106: 2854-61
|
|
|
|
|
|
12) Shimada A, Taki T, Kubota C, et al. No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group. Leukemia. 2007; 21: 1307
|
|
|
|
|
|
13) Cirstea IC, Kutsche K, Dvorsky R, et al. A restricted spectrum of NRAS mutations cause Noonan syndrome. Nature Genet. 2010; 42: 27-9
|
|
|
|
|
|
14) Aoki Y, Niihori T, Kawame H, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nature Genet. 2005; 37: 1038-40
|
|
|
|
|
|
15) Zenker M, Lehmann K, Schulz AL, et al. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet. 2007; 44: 131-5
|
|
|
|
|
|
16) Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010; 24: 101-22
|
|
|
|
|
|
17) Calado RT, Regal JA, Hills M, et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A. 2009; 106: 1187-92
|
|
|
|
|
|
18) Chakraborty S, Sun CL, Francisco L, et al. Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol. 2009; 27: 791-8
|
|
|
|
|
|
19) Rubnitz JE, Inaba H, Dahl G, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010; 11: 543-52
|
|
|
|
|